Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVP-0962 single- and multiple-ascending-dose study in healthy volunteers
NL-OMON35950Active, not recruiting
- Sponsor
- FORUM Pharmaceuticals
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of EVP-0962 in Alzheimer's disease (AD) (4 arms), sponsored by FORUM Pharmaceuticals. Primary endpoints: Safety and Tolerability. Started Apr 2011; status: active, not recruiting.
02
Drugs
EVP-0962
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NL-OMON35950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35950.